Now that CMS has released 2021 updates for agents and brokers, it’s important to explore these changes in the context of COVID-19 and how standard Medicare selling practices will not be sufficient for this year’s AEP.
With CMS’ release of the Contract Year 2021 Final Rule, MA plans now have some clarity regarding the many Star Ratings proposals made earlier this year.
In a recent webinar presented with Deft Research, GHG shared the key lessons learned from the 2020 AEP results. Read a synopsis of what these lessons entail and watch the webinar recording on demand.
On March 30, 2020, CMS released the interim final rule with comment period (IFC) to address a variety of payment and provider practice needs in response to the COVID-19 pandemic. Read the key takeaways for Star Ratings, Provider Flexibilities, and Telehealth.
The 2021 Medicare Advantage and Part D Rate Announcement finalizes the payment methodology and policies previously proposed by the Advance Notice. What’s been confirmed? Read this article for details.
In a recent webinar, GHG shared the critical trends in supplemental benefits from the AEP results data that health plans need to know going into 2021 bids. Read a summary of the key takeaways and view the webinar recording on demand.
On March 30, 2020, CMS announced temporary regulatory waivers and new rules to help the U.S. healthcare system continue operating through President Trump’s COVID-19 emergency declaration. With this new information, GHG’s Star Ratings expert, Melissa Smith, answers many of the FAQs we’ve received over the last few weeks.
CMS has announced significant temporary changes to Star Ratings in response to the COVID-19 pandemic to provide some relief to healthcare organizations, but we still have many unanswered questions. Here’s what we know so far.
CMS has published key information regarding 2021 MA Part C & D bids, payments and rules in a series of documents released 2/5/2020. Here’s what you should know.
The Office of Inspector General (OIG) report on the use of chart reviews in Medicare Advantage risk adjustment raises a number of concerns for Medicare Advantage Organizations (MAOs). How can plans mitigate risk from chart review submissions and stay compliant with CMS risk adjustment guidelines to ensure complete and accurate reimbursement?